Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01) ...Middle East

PR Newswire - News
CPL-01, for Non-Opioid Treatment of Post-Operative Pain, Garners Publication of Clinical Data in Abdominoplasty and Presentation of Preclinical Data in Bony and Soft-Tissue Models Supporting Pharmacokinetics and Safety SAN DIEGO, Oct. 26, 2022 /PRNewswire/ -- Cali Biosciences Co., Ltd....

Hence then, the article about cali biosciences announces publications of phase iia results of long acting ropivacaine cpl 01 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01) )

Apple Storegoogle play

Last updated :

Also on site :



Latest News